Validation of warfarin pharmacogenetic algorithms in 586 Han Chinese patients

被引:1
|
作者
Peng, Qi [1 ]
Huang, Shujun [2 ]
Chen, Xiaoying [3 ]
Yuan, Yayan [2 ]
Yu, Yajun [2 ]
Tao, Liang [1 ]
Zhang, Zhenlu [4 ]
Xu, Mousheng [2 ]
机构
[1] Wuhan Asia Heart Hosp, Cardiac Surg, Wuhan 430022, Hubei, Peoples R China
[2] Hubei Vidagen Gene Technol Co Ltd, Wuhan 430075, Hubei, Peoples R China
[3] Wuhan Asia Heart Hosp, Dept Cardiol, Wuhan 430022, Hubei, Peoples R China
[4] Wuhan Asia Heart Hosp, Clin Test Ctr, Wuhan 430022, Hubei, Peoples R China
关键词
algorithm; Chinese; clinical accuracy; dose; pharmacogenetics; warfarin; HEART-VALVE REPLACEMENT; DOSE REQUIREMENTS; DOSING ALGORITHM; COMPARATIVE PERFORMANCE; MULTIETHNIC POPULATION; ATRIAL-FIBRILLATION; CYP2C9; GENOTYPES; BODY-WEIGHT; VKORC1; ANTICOAGULATION;
D O I
10.2217/PGS.15.87
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim: To compare the accuracy of the nine selected algorithms for predicting warfarin dose with 586 Han Chinese patients. Materials & methods: Genotyping of VKORC1 1639G>A, CYP2C9*2 and CYP2C9*3 variants was performed. Both the mean absolute error and ideal estimation value were used for comparison. Results: The top three performers were from East Asians. The algorithms from Caucasians generally performed better in the medium-dose subgroup (>3 and <7 mg/day), while the algorithms from East Asians generally performed better in the low-dose subgroup (<= 3 mg/day). None of the algorithms performed well in the high-dose subgroup (>= 7 mg/day). Conclusion: Algorithms built for specific ethnic groups and p-reassigned-dose groups are suggested for better prediction.
引用
收藏
页码:1465 / 1474
页数:10
相关论文
共 50 条
  • [31] Estimation of the warfarin dose with a pharmacogenetic refinement algorithm in Chinese patients mainly under low-intensity warfarin anticoagulation
    Xu, Qiang
    Xu, Bin
    Zhang, Yuxiao
    Yang, Jie
    Gao, Lei
    Zhang, Yan
    Wang, Hongjuan
    Lu, Caiyi
    Zhao, Yusheng
    Yin, Tong
    [J]. THROMBOSIS AND HAEMOSTASIS, 2012, 108 (06) : 1132 - 1140
  • [32] Pharmacogenetic Testing for Warfarin Dosing Still Awaits Validation Reply
    Epstein, Robert S.
    Moyer, Thomas P.
    Aubert, Ronald E.
    O'Kane, Dennis J.
    Xia, Fang
    Teagarden, J. Russell
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (06) : 756 - 757
  • [33] Comparative accuracy of pharmacogenetic warfarin dosing algorithms and the warfarin dosing label plus clinical judgment
    Labinov, Yana
    DiDomenico, Robert
    Nutescu, Edith A.
    Cavallari, Larisa H.
    [J]. PHARMACOTHERAPY, 2013, 33 (10): : E190 - E190
  • [34] Comparison of warfarin pharmacogenetic dosing algorithms in a racially diverse large cohort
    Shin, Jaekyu
    Cao, Diana
    [J]. PHARMACOGENOMICS, 2011, 12 (01) : 125 - 134
  • [35] Comparison of Nine Statistical Model Based Warfarin Pharmacogenetic Dosing Algorithms Using the Racially Diverse International Warfarin Pharmacogenetic Consortium Cohort Database
    Liu, Rong
    Li, Xi
    Zhang, Wei
    Zhou, Hong-Hao
    [J]. PLOS ONE, 2015, 10 (08):
  • [36] Performance Evaluation of Warfarin Dose Prediction Algorithms and Effects of Clinical Factors on Warfarin Dose in Chinese Patients
    Gao, Weiqi
    Li, Zhihong
    Chen, Weihong
    Zhang, Shuqiu
    [J]. THERAPEUTIC DRUG MONITORING, 2021, 43 (04) : 527 - 535
  • [37] Implications of Pharmacogenetic Testing for Patients Taking Warfarin or Clopidogrel
    Megan M. Donohue
    David L. Tirschwell
    [J]. Current Neurology and Neuroscience Reports, 2011, 11 : 52 - 60
  • [38] Chinese Patients With Heart Valve Replacement Do Not Benefit From Warfarin Pharmacogenetic Testing on Anticoagulation Outcomes
    Hao, Yexia
    Yang, Jun
    Zheng, Xuan
    Hu, Yuanping
    Yan, Xinsheng
    Zhang, Litao
    [J]. THERAPEUTIC DRUG MONITORING, 2019, 41 (06) : 748 - 754
  • [39] Implications of Pharmacogenetic Testing for Patients Taking Warfarin or Clopidogrel
    Donohue, Megan M.
    Tirschwell, David L.
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2011, 11 (01) : 52 - 60
  • [40] Genetic determinants of warfarin dosing in the Han-Chinese population
    Lee, M. T. Michael
    Chen, Chien-Hsiun
    Chou, Ching-Heng
    Lu, Liang-Suei
    Chuang, Hui-Ping
    Chen, Ying-Ting
    Saleem, Amir N.
    Wen, Ming-Shien
    Chen, Jin-Jer
    Wu, Jer-Yuarn
    Chen, Yuan-Tsong
    [J]. PHARMACOGENOMICS, 2009, 10 (12) : 1905 - 1913